However, the guidelines do not provide a reference for patients ineligible for radiotherapy.[3] Head and neck squamous cell carcinoma tumors are highly inflammatory with lymphocytic infiltration and strong programmed death ligand 1 (PD-L1) expression on tumor cells and cells within the tumor microenvironment (TME). The gene discussed is CD274; the disease is neoplasm.